BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 37619678)

  • 1. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
    Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.
    Muhamad N; Plengsuriyakarn T; Chittasupho C; Na-Bangchang K
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):935-941. PubMed ID: 32334453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.
    Yuan H; Gui H; Chen S; Zhu L; Wang C; Jing Q; Lv H; Wan Q; Wang S; Zhou S; Ren X; Nie Y; Li L
    Int J Nanomedicine; 2024; 19():3589-3605. PubMed ID: 38645464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability.
    Lu Y; Wang JT; Li N; Zhu X; Li Y; Bansal S; Wang Y; Al-Jamal KT
    J Control Release; 2023 Jul; 359():257-267. PubMed ID: 37290723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization.
    Durán-Lobato M; Álvarez-Fuentes J; Fernández-Arévalo M; Martín-Banderas L
    Sci Rep; 2022 Jan; 12(1):1297. PubMed ID: 35079042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport.
    Gandhi S; Shastri DH; Shah J; Nair AB; Jacob S
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface Functionalized Lipid Nanoparticles in Promoting Therapeutic Outcomes: An Insight View of the Dynamic Drug Delivery System.
    Manchanda N; Vishkarma H; Goyal M; Shah S; Famta P; Talegaonkar S; Srivastava S
    Curr Drug Targets; 2024; 25(4):278-300. PubMed ID: 38409709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine.
    Sharma S; Tyagi A; Dang S
    Int J Biol Macromol; 2023 Dec; 252():126471. PubMed ID: 37619678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
    Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
    Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
    Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysorbate 80 surface modified PLGA nanoparticles: an
    Sharma S; Dang S
    J Microencapsul; 2023 Nov; 40(7):534-548. PubMed ID: 37530105
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.